Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.

Efficacy, Safety and Acceptability of the New Pen Needle 33G x 4 mm: a Cross-over Randomised Non Inferiority Trial

The purpose of this study is to determine the non-inferiority of a new Pic Insupen 34Gx3,5mm needle vs. a 32Gx4mm needle in terms of metabolic control, safety and acceptability in patients with diabetes treated with insulin.

Inclusion Criteria:

• Patients with type 1 or type 2 diabetes
• Age >= 18 years
• Multiple daily injections of insulin for at least 6 months
• Signed informed consent

Exclusion Criteria:

• Pregnancy or or breast feeding
• Inability to fill in the questionnaire
• Combined therapy for diabetes (oral drugs associated with insulin injections)
• Any medical condition that could interfere with the study according to the investigator's opinion